Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

22 Oct 2024 07:00

RNS Number : 0321J
System1 Group PLC
22 October 2024
 

 

 

 

 

22 October 2024

 

 

System1 Group PLC (AIM: SYS1)

 ("System1", or "the Company", or "the Group")

Quarter 2 and Half Year Trading Update

 

 

 

System1, the marketing decision-making platform www.system1group.com today issues an update on trading for the quarter ended 30 September 2024 (Q2 FY25) and the half-year ended 30 September 2024 (H1 FY25) in advance of its interim results announcement scheduled for 3 December 2024.

 

 

 

Quarter 2

Platform Revenue increased by 35% to £8.2m with data sales 32% and data-led consultancy 53% higher than in the same period last year. Platform Revenue comprised 92% of Total Group Revenue in Q2 FY25 (Q2 FY24: 85%). As announced in July, Platform Revenue in the previous quarter (Q1) was £8.6m reflecting an exceptionally strong period, and ahead of our own expectations. Total Q2 FY25 Revenue of £8.9m grew by 25% on Q2 FY24, including the impact of lower non-platform revenues. Growth in Group Revenue was driven mainly by the US where Total Revenue rose by over 60% and Platform Revenue by over 75% compared with Q2 FY24.

 

 

Half Year

The Company won over 160 new platform clients in H1 FY25 (H1 FY24: 136), including a global short-form video hosting platform, a leading global automotive business, and an international food delivery business.

Platform Revenue in H1 FY25 increased by 53% versus H1 FY24 to £16.7m with data sales 48% and data-led consultancy 76% higher. Total H1 FY25 Revenue of £18.3m was 38% above the same period last year, including the impact of a £0.7m reduction in non-platform business. Growth in Revenue was driven mainly by the US where Platform Revenue was more than double H1 FY24. Platform Revenue comprised 91% of Total Group Revenue in H1 FY25 (H1 FY24: 82%). Revenue growth in H1 derived from Ad testing (Comms), with Brand and Innovation product groups broadly in line with H1 FY24.

 

Gross Profit in H1 FY25 reached £16.0m at a margin of 87.3% (H1 FY24: £11.7m at 87.8% margin). Operating expenditure increased by £2.6m (+23% on H1 FY24), due to increased investment in people, product and marketing to fuel the next phase of growth.

 

Based on the unaudited management accounts, the Group expects to report a Statutory Pre-Tax Profit of ca £2.5 million for the half-year including a £0.1m credit to share-based payments (H1 FY24: £0.9m).

 

Free cashflow in H1 was in line with our plan, with an outflow of £0.3m, due mainly to the payment of £2.6m of FY24 performance bonuses. The reduction in the value of the US dollar and other currencies against Sterling, notably in September, reduced the converted value of non-Sterling bank balances by £0.4m compared to 31 March 2024 and, combined with the free cash outflow, resulted in a 30 September 2024 cash balance of £8.9m (31 March 2024: £9.6m; 30 September 2023: £6.3m).

 

Commenting on the trading update, CEO James Gregory said: "I am delighted that our focus on winning in America is delivering strong growth and financial results. We are continuing to win and retain business with the world's largest advertisers and will be accelerating and significantly increasing investment in the coming months to build our position in America and revitalise System1's Innovation proposition."

 

Interim Results

The Company intends to release interim results for the half-year ended 30 September 2024 on 3 December 2024.

 

Further information on the Company can be found at www.system1group.com.

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) 596/2014 as amended by regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310. With the publication of this announcement, this information is now considered to be in the public domain.

 

For further information, please contact:

System1 Group PLC

Tel: +44 (0)20 7043 1000

James Gregory, Chief Executive Officer

Chris Willford, Chief Financial Officer

 

Canaccord Genuity Limited (Nominated Adviser & Broker)

 

Tel: +44 (0)20 7523 8000

 

Simon Bridges / Andrew Potts / Harry Rees

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUAARRSKURUUA
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.